Stonebridge Capital Advisors LLC Editas Medicine, Inc. Transaction History

Stonebridge Capital Advisors LLC

  • $1.19 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$9.99 - $21.35 $1,198 - $2,562
-120 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$39.71 - $90.58 $4,765 - $10,869
120 New
120 $5,000
Q3 2020

Nov 18, 2020
SELL
$28.06 - $37.16 $3,367 - $4,459
-120 Closed
0 $0
Q2 2019

Aug 15, 2019
BUY
$20.48 - $27.76 $2,457 - $3,331
120 New
120 $3,000

Others Institutions Holding EDIT

# of Institutions
248
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $90M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Stonebridge Capital Advisors LLC Portfolio

Follow Stonebridge Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email